HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

acipimox

lipolysis inhibitor
Also Known As:
5-methylpyrazine-2-carboxylic acid 4-oxide; 5-methylpyrazinecarboxylic acid 4-oxide; Nedios; Olbemox; Olbetam
Networked: 142 relevant articles (22 outcomes, 32 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Møller, Niels: 5 articles (12/2020 - 10/2010)
2. Jessen, Niels: 3 articles (12/2020 - 01/2017)
3. Jørgensen, Jens Otto Lunde: 3 articles (01/2019 - 01/2017)
4. DeFronzo, Ralph A: 3 articles (03/2016 - 09/2004)
5. Bajaj, Mandeep: 3 articles (06/2007 - 09/2004)
6. Jørgensen, Jens O L: 2 articles (12/2020 - 03/2007)
7. Vestergaard, Esben Thyssen: 2 articles (01/2019 - 12/2017)
8. Mari, Andrea: 2 articles (01/2018 - 03/2016)
9. Torriani, Martin: 2 articles (03/2016 - 11/2006)
10. Nowotny, Peter: 2 articles (04/2015 - 03/2014)

Related Diseases

1. Insulin Resistance
2. Type 2 Diabetes Mellitus (MODY)
3. Hypertriglyceridemia
4. Dyslipidemias (Dyslipidemia)
5. Hyperlipidemias (Hyperlipidemia)

Related Drugs and Biologics

1. Glucose (Dextrose)
2. Lipids
3. Insulin (Novolin)
4. Nonesterified Fatty Acids (NEFA)
5. Triglycerides (Triacylglycerol)
6. Pravastatin (Pravachol)
7. Lovastatin (Mevacor)
8. Omega-3 Fatty Acids (Omega 3 Fatty Acids)
9. Adenosine Triphosphate (ATP)
10. Fatty Acids (Saturated Fatty Acids)

Related Therapies and Procedures

1. Therapeutics
2. Glycemic Control
3. Drug Therapy (Chemotherapy)
4. Oral Administration